Outcomes improving for younger patients with follicular lymphoma
the ONA take:
Patients younger than 40 years with follicular lymphoma have a median overall survival of 24 years and their outcome seems to be improving over time, according to a recent study published online ahead of print in the journal Annals of Oncology.
For the study, investigators sought to evaluate the clinical features and outcomes of younger patients with follicular lymphoma.
Researchers retrospectively analyzed data from 1,002 patients with follicular lymphoma diagnosed in Spain, Switzerland, United Kingdom, or Italy between 1985 and 2010.
Results showed that at a median follow-up of 10 years, younger patients had significantly better overall survival, cause-specific survival, and progression-free survival compared with those older than 40 years.
Researchers found that patients with a lymphoma diagnosis in the last two decades and having a Follicular Lymphoma International Prognostic Index (FLIPI) score were associated with a significantly longer progression-free survival and cause-specific survival in patients younger than 40 years. A favorable FLIPI score was significantly associated with longer overall survival.
Patients younger than 40 years with follicular lymphoma have a median overall survival of 24 years.
- Acupuncture Improves Postoperative Symptoms in Women Undergoing Surgery for Breast Cancer
- Prehabilitation Program Improves Preoperative Fitness in Patients With Colorectal Cancer
- Alcohol Consumption, Particularly White Wine, Associated With Increased Risk of Melanoma
- Combination of Gemcitabine and New CHK1 Inhibitor Is Effective in Soft Tissue Sarcomas
- Omitting RT in Certain Older Women With Early Breast Cancer is Safe
- Walnut Consumption Changes Gut Microbiome, Decreases Growth of Colon Cancer in Mice
- Vaccine Enters Phase I Study for Safety and Effectiveness in Multiple Myeloma
- Timing Chemotherapy Administration to Circadian Rhythm Improves Drug Effectiveness
- New Therapy Blocks Breast Cancer Cells From Entering and Hiding in Bone Marrow to Form Latent Metastases
- Baseline PSA Levels in Midlife Could Predict Risk of Lethal Prostate Cancer
- Community Breast Navigation Program Improved Breast Screening Rates in Underserved African American and Latino Women
- Live-streamed Videos Address End-of-Life Planning, Decision-making
- Metastatic Disease Linked to Patients Reporting Diminished QoL
- History of Bilateral Salpingo-oophorectomy, Hormone Replacement Therapy Are Predictive of Breast Density at Cancer Diagnosis
- Mammographically Occult Contralateral Breast Cancer Detection is Effective With Preoperative MRI
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|